Responses
Association of British Neurologists Annual Meeting 2012
123
FROM BIOLOGY TO THE BEDSIDE-SIRTUINS AS TARGETS FOR DISEASE MODIFICATION IN HUNTINGTON'S DISEASE: SELISISTAT PRECLINICAL DATA AND PRELIMINARY PHASE I RESULTS
Compose a Response to This Article
Other responses
No responses have been published for this article.